Comparison 1. Methotrexate versus placebo.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 Proportion of patients maintaining clinical remission | 2 | Risk Ratio (M‐H, Fixed, 95% CI) | Totals not selected | |
1.1 Intramuscular methotrexate | 1 | Risk Ratio (M‐H, Fixed, 95% CI) | 0.26 [0.04, 0.48] | |
1.2 Low dose oral methotrexate | 1 | Risk Ratio (M‐H, Fixed, 95% CI) | 0.23 [‐0.09, 0.56] |